Through the Growth Centre Project Fund, MTPConnect committed $15.6M across 40 collaborative projects, engaging over 190 consortium members.
Projects supported through this program, an initiative of the Australian government, achieved substantial results. From 2017 until the end of FY2022, these projects have resulted in:
488 new technologies being invented or progressed
549 patents/trademark applications and licences
150 start-up companies formed
1,525 new jobs created
More than $257 million of investment has flowed into incubator companies
Over 240,000 patients have been impacted, with over 780 clinical or preclinical trials commenced.
Growth Centre Project Fund – Projects are detailed in this summary
Australia’s first Antimicrobial Resistance Network forms to combat global health threat
MTPConnect today announced the formation of an Australian-first network bringing together key stakeholders to address the impact of antimicrobial resistance …
